Skip to content

Transcranial Alternating Current Stimulation

Transcranial Alternating Current Stimulation (tACS) Enhances Neurological Function Recovery Among Post-stroke Patients

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01200719
Enrollment
312
Registered
2010-09-14
Start date
2006-11-30
Completion date
2009-09-30
Last updated
2010-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

brain electrical stimulation, sub-acute post-stroke, rehabilitation

Brief summary

To investigate the efficacy of using transcranial alternating current stimulation (tACS) to enhance the regaining of neurological function among post-stroke patients.

Detailed description

Sixty post-stroke patients were randomly assigned to receive 15 sessions of the usual rehabilitation programme with or without tACS. The NIH Stroke Scale (NIHSS) and the mean blood flow velocity (MFV) and Gosling pulsatility index (PI) captured for the middle, anterior, and posterior cerebral artery were the outcome measures. Fifteen 30-minute sessions of tACS appear to be effective for enhancing post-stroke patients' neurological function. The haemodynamic measures taken indicated that the regaining of function among the patients was largely attributed to a lowering of the vascular autoregulatory activity together with an increase in blood flow velocity at the middle cerebral artery. Future studies should explore the underlying mechanisms mediating the positive effects brought about by tACS in post-stroke rehabilitation.

Interventions

DEVICEtranscranial alternating current stimulation (tACS)

Patients in the tACS group received a total of 15 sessions of brain stimulation. The sessions were conducted on weekdays (from Monday to Friday) for three consecutive weeks. Each session lasted 30 minutes. The alternating current stimulations were generated by a CVFT-MG201 machine. Stimulations were delivered by two U-shaped electrodes (approximately 7 cm2) fixed on the patient's left and right mastoid regions (anode or cathode varied depending on polarity of the alternating current). The frequencies (supra-slow waves: \< 1 Hz; theta to gamma), levels of intensities (0 to 3mA), and density function (follows a bell-shaped curve; mean intensity \ 2.1mA) of the current were delivered according to the manufacturer's pre-set random protocol.

Sponsors

The Hong Kong Polytechnic University
CollaboratorOTHER
Fudan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 79 Years
Healthy volunteers
No

Inclusion criteria

* diagnosed as first onset intracerebral haemorrhage or infarction (according to ICD-10 I61.0-I61.6 or I63.3-I63.6, with or without I69, i.e.: sequelae of cerebrovascular disease) * between 15 and 60 days after the onset * right handedness * no previous neurological or psychiatric disorders * positive transtemporal windows for bilateral middle, anterior, and posterior cerebral arteries insonation (according to the standards set by the Transcranial Doppler Ultrasonographic Device (TCD)) * NIH Stroke Scale (NIHSS) scores between 14 and 24 * not receiving rehabilitation before admission

Exclusion criteria

* medical comorbidity preventing the patient undergoing the intervention * preceding epileptic fits * having metallic implants in the brain or a pacemaker * history of surgery to the brain

Design outcomes

Primary

MeasureTime frame
NIH Stroke Scale (NIHSS) score3 weeks

Secondary

MeasureTime frameDescription
the mean blood flow velocity (MFV)30 minutescaptured for the middle, anterior, and posterior cerebral artery by transcranial Doppler
Gosling pulsatility index (PI)30 minutescaptured for the middle, anterior, and posterior cerebral artery by transcranial Doppler

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026